Skip to main content
. 2026 Mar 16;15(3):320. doi: 10.3390/pathogens15030320
BDQ bedaquiline
DLM delamanid
gDST phenotypic drug susceptibility testing
INH isoniazid
LVX levofloxacin
LZD linezolid
MDR-TB multidrug-resistant tuberculosis
MFX moxifloxacin
MIC minimum inhibitory concentration
pDST phenotypic drug susceptibility testing
PMD pretomanid
REMA resazurin microdilution assay
RIF rifampicin
RR-TB rifampicin-resistant TB
TB tuberculosis
WGS whole-genome sequencing
WHO World Health Organization
XDR-TB extensively drug-resistant tuberculosis